New Delhi, July 31 -- Washington - In a political maneuver wrapped in populist outrage and regulatory theatrics, President Donald Trump has launched a renewed offensive against the pharmaceutical industry, pressuring 17 of the world's most powerful drugmakers to slash prices for American consumers-or face punitive consequences. In letters dispatched this week to the CEOs of major firms including Pfizer, [.]

Published by HT Digital Content Services with permission from The Eastern Herald....